HB4721Introduced in the House of Delegates
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
Introduced by Rick Hillenbrand, District 88
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
The purpose of this bill is to add a provision in Schedule I drugs relating to the scheduling of crystalline polymorph psilocybin, if approved by the Food and Drug Administration and the Drug Enforcement Administration, and declare that will be lawful to prescribe, distribute and market this drug.
Where it stands
To House Health and Human Resources
January 22, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Filed for introduction
To Health and Human Resources then Judiciary
Introduced in House
To House Health and Human Resources
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.